BioCentury
ARTICLE | Clinical News

Xpert HemosIL Fll and FV Assay regulatory update

June 8, 2009 7:00 AM UTC

Health Canada granted a medical device license for Cepheid's Xpert HemosIL FII and FV test to detect Factor II and Factor V Leiden genetic variations associated with thrombophilia. The molecular diag...